MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
Therapeutic Advances in Psychopharmacology
Published online on March 31, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, XX 2026.
Background:Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroRNAs (miRNAs) have emerged ...
Background:Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroRNAs (miRNAs) have emerged ...